Publication | Open Access
Targeted Axl Inhibition Primes Chronic Lymphocytic Leukemia B Cells to Apoptosis and Shows Synergistic/Additive Effects in Combination with BTK Inhibitors
72
Citations
43
References
2015
Year
Administration of TP-0903 either as a single agent or in combination with BTK inhibitors may be effective in treating patients with CLL.
| Year | Citations | |
|---|---|---|
Page 1
Page 1